Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

C4.4A / LYPD3 Antikörper

Produkt-Information von C4.4A / LYPD3 Antikörper

Immunogen

Recombinant Human C4.4A / LYPD3 protein (Catalog#11836-H08H)

Antibody Type Rabbit Monoclonal Antibody ( Rabbit mAb Service Platform )

Clone ID

213

Ig Type

Rabbit IgG

Formulation 0.2 μm filtered solution in PBS with 5% trehalose
Preparation

This antibody was obtained from a rabbit immunized with purified, recombinant Human C4.4A / LYPD3 (rh C4.4A / LYPD3; Catalog#11836-H08H; NP_055215.2; Met 1-His 286).

Usage Guide von C4.4A / LYPD3 Antikörper

Specificity

Human C4.4A / LYPD3

Western blot This antibody can be used at 1-2 μg/mL with the appropriate secondary reagents to detect Human LYPD3 in WB under non-reducing conditions and not recommended under reducing conditions.
Direct ELISA This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human LYPD3. The detection limit for Human LYPD3 is approximately 0.0049 ng/well.
Storage This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

Verwandte Produkte & Themen von C4.4A / LYPD3 Antikörper

Related Areas:
Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
C4.4A/LYPD3 Human C4.4A/LYPD3 Protein, Recombinant 11836-H08H
C4.4A/LYPD3 Mouse C4.4A/LYPD3 Protein, Recombinant 50546-M08H
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human C4.4A/LYPD3 WB, ELISA C4.4A / LYPD3 Antibody (Antigen Affinity Purified) 11836-RP02
Human C4.4A/LYPD3 WB, ELISA C4.4A / LYPD3 Antibody 11836-R213
Mouse C4.4A/LYPD3 WB, ELISA C4.4A / LYPD3 Antibody 50546-RP01
Mouse C4.4A/LYPD3 WB, ELISA C4.4A / LYPD3 Antibody (Antigen Affinity Purified) 50546-RP02

Hintergrund von C4.4A / LYPD3 Antikörper

Ly6 / PLAUR domain-containing protein 3, also known as GPI-anchored metastasis-associated protein C4.4A homolog, Matrigel-induced gene C4 protein, MIG-C4 and LYPD3, is a cell membrane protein which contains twoUPAR/Ly6 domains. Human LYPD3 contains twoUPAR/Ly6 domains. LYPD3 is expressed in placenta, skin and urothelium. It is found in suprabasal keratinocytes of chronic wounds. Weak expression of LYPD3 is found in esophagus and peripheral blood mononuclear cells. It is found in the majority of primary and metastatic transitional cell carcinomas (TCCs) and as well in breast cancer tissues, but not in adjacent normal tissues. High expression of LYPD3 is found in the tumor component of some noninvasive superficial lesions and in invasive and metastatic urothelial cancers. LYPD3 is up-regulated in migrating keratinocytes during epithelisation of incisional skin wounds. LYPD3 supports cell migration. It may be involved in urothelial cell-matrix interactions. It may also be involved in tumor progression.

References

  1. Smith B.A., et al., 2001, Cancer Res. 61: 1678-85.
  2. Wuerfel J., et al., 2001, Gene. 262: 35-41.
  3. Clark H.F., et al., 2003, Genome Res. 13: 2265-70.
  4. Fletcher G.C., et al., 2003, Br. J. Cancer. 88: 579-85.
  5. Hansen L.V., et al., 2004, Biochem. Eng. J. 380: 845-57.

Sino Biological Inc. liefert C4.4A / LYPD3 Antikörper mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über C4.4A / LYPD3 Antikörper lesen Sie bitte: http://www.sinobiological.com/C4.4A-LYPD3-Antibody-g-9483.html

Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post